Examining trends in polydrug overdose deaths across rural Midwest counties in the United States, 2022 through 2024

分析2022年至2024年美国中西部农村地区多种药物过量致死的趋势

阅读:1

Abstract

PURPOSE: To examine trends in overdose deaths and the presence of xylazine in postmortem toxicology in a highly rural region of northern Minnesota with a significant American Indian/Alaska Native (AI/AN) population, using real-time local surveillance data. METHODS: We analyzed drug overdose death data from the Midwest Medical Examiner's Office, covering 36 counties from January 1, 2022 to December 31, 2024. Data included demographic characteristics, place of death, and substances detected in toxicology results. Age-adjusted mortality rates and disparities across racial/ethnic groups were calculated, and polydrug combinations were explored using network analysis. FINDINGS: Among 967 overdose deaths, most decedents were white (71.7 %), AI/AN (13.4 %), or Black/African American (10.3 %) with an overall mortality rate of 76.1. Mortality rates declined during the study period for white and AI/AN populations and increased slightly for Black/African American populations. However, rates remained disproportionately high for AI/AN populations, who were 6.19 times more likely to die of overdose than non-AI/AN in 2024. Xylazine was detected only in combination with fentanyl, with no racial/ethnic differences in its presence. Distinct polydrug patterns were observed by race: fentanyl-cocaine combinations were more prevalent among Black/African Americans, while fentanyl-methamphetamine combinations predominated among AI/AN and White decedents. CONCLUSIONS: Local surveillance in rural areas can detect emerging threats like xylazine and illuminate racial disparities obscured in national datasets. Findings highlight the urgent need for real-time, locally driven data to inform targeted prevention and harm reduction, particularly for AI/AN populations in rural communities.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。